Key Takeaways:
- BCF Life Sciences leverages amino acid blends derived from poultry feather keratin to develop biostimulants.
- BCF Life Sciences plans to double its plant care sales by 2030 and increase production capacity by 50%.
- Soil health, microbial synergy, and abiotic stress mitigation are key areas of product innovation.
- BCF Life Sciences emphasizes transparency with a scope-three carbon footprint analysis and CSR-driven investments.
- Regulatory clarity is helping to professionalize the biostimulant industry, according to leadership.
From Poultry Byproduct to Plant Nutrition
The origins of BCF Life Sciences
BCF Life Sciences’ journey into the world of biostimulants was neither planned nor immediate. Founded 37 years ago in Brittany, France, the company began as a response to an industrial challenge. The parent company operated in the poultry sector and was left with vast quantities of feathers—rich in keratin but previously viewed as waste. Upon further investigation, keratin was found to be a valuable source of free amino acids, especially cystine.
“BCF Life Sciences was created through a circular economy model,” said Jean-Marie Lecuyer, Head of the Plant Care Business Unit at BCF Life Sciences, in an interview with iGrow News. “It started with the idea of finding value in feathers, and eventually opened a path to amino acid production for pharmaceuticals and food supplements.”
Transition to Biostimulants
Serendipitous entry into agriculture
The shift toward plant care came unexpectedly. Lecuyer explained that initial conversations with companies in Spain and Italy revealed agricultural interest in BCF Life Sciences’s amino acid formulations. “Our customers discovered the efficacy of our product mix for biostimulant use before we even realized the potential,” he said.
BCF Life Sciences formalized its entry into the plant care segment by 2017, hiring R&D personnel to understand the mode of action behind their amino acid blends. By 2020, they established a dedicated plant care team and began expanding internationally. “We didn’t build new products initially. We adapted what we already had, and it turned out to be a great market fit,” said Lecuyer.
Product Innovation and Application Trends
Expanding beyond foliar use
BCF Life Sciences’s early formulations targeted foliar application, but ongoing R&D has revealed new possibilities. The company is now developing products for seed treatments and in-furrow applications—particularly relevant for crops like corn. Lecuyer emphasized their recent patent for stimulating soil microflora, marking a significant shift in their strategy.
“We’ve always seen amino acids applied above ground. But now, the soil is a new frontier,” he said. “We’re orienting our next generation of products toward soil health, which is largely untapped.”
BCF Life Sciences also focuses on combining amino acids with micronutrients and other compounds to enhance bioavailability and deliver specific agronomic benefits. “We’re not just selling a product—we’re offering targeted solutions,” Lecuyer added.
Regional Expansion and Market Focus
Customized solutions across geographies
BCF Life Sciences operates in a B2B capacity, providing turnkey formulations for distributors and mid-to-large agribusinesses. Their amino acid blends are now used across high-value horticultural crops and increasingly in arable crops like wheat, corn, and soybean.
“Initially, only specialty crop growers could afford biostimulants,” said Lecuyer. “But now, farmers in large-scale agriculture are seeing the value—especially for mitigating abiotic stress.”
The company tailors its strategy to local needs, with business developers identifying priority issues in each market. In Europe, there’s demand for stress mitigation in winter wheat. In India and Indonesia, the focus is on heat and soil stress, respectively. “We don’t offer a one-size-fits-all product,” Lecuyer said. “We identify the highest-impact use cases and develop accordingly.”
Regulatory Environment and Market Maturity
Finding clarity in evolving frameworks
Lecuyer acknowledged that regulatory hurdles have historically slowed progress in the biostimulant industry. However, the 2019 European regulation, now being fully implemented, is a turning point.
“It brings clarity. It separates serious players from those who don’t have performance data,” he said.
Still, he noted that for animal-derived hydrolysates, categorization has been slow and complex. Outside Europe, the U.S. and other markets are actively exploring their own regulatory structures. Regardless of these differences, Lecuyer observed global enthusiasm for biostimulant adoption. “Agronomists everywhere—from Africa to Southeast Asia—are eager to innovate,” he said.
Corporate Strategy and Vision for 2030
Investment, acquisition, and future growth
BCF Life Sciences’s ambitions for 2030 are backed by strong financial and structural support. In 2024, the company was acquired by Sparkfood, part of the Portuguese conglomerate Sonae, which recently acquired a majority stake in the company. Sonae, with its size,, aims to help BCF Life Sciences scale significantly.
“We plan to increase our production capacity by 50% and double our plant care sales from €10–12 million to €20–25 million,” Lecuyer said.
To achieve this, the company is expanding its team and its footprint. New hires are planned in North America and Brazil by the end of 2025. “Africa is also on our radar,” Lecuyer added. “There’s a lot of energy and need for sustainable solutions there.”
A Commitment to Sustainability
Leading with transparency and innovation
BCF Life Sciences Life Sciences also differentiates itself through its commitment to corporate social responsibility (CSR). The company has conducted a scope-three carbon footprint assessment—an uncommon move in the industry. “We know the footprint of our entire supply chain,” said Lecuyer.
In addition, BCF Life Sciences is researching how its products contribute to carbon sequestration by enhancing root growth, biomass, and by reducing the doses of fertilizer applied to the crop while keeping yields. “Biostimulants can play a key role in regenerative agriculture,” he said, emphasizing that practices like cover cropping and low tillage, combined with targeted biostimulant use, can reduce atmospheric carbon.
The company has also invested €6 million in a water treatment facility at its Brittany plant, further reducing its environmental impact.
Looking Ahead
As the biostimulant sector continues to grow at double-digit rates, BCF Life Sciences is positioning itself as a global leader in amino acid-based plant care solutions. With a focus on R&D, market-specific strategies, and sustainability, the company aims to expand its influence while maintaining its B2B specialty model.
“We don’t pretend to solve everything,” Lecuyer concluded. “But with focus, science, and the right partners, we can bring meaningful solutions to farmers around the world.”
Follow them on LinkedIn
